Small intestinal bacterial overgrowth in children: An expert review by the ESPGHAN Gastroenterology Committee
- 29 July 2025
- journal article
- review article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (4) , 986-999
Abstract
The aim of this review is to summarize the prevalence, etiology, pathogenesis, diagnosis, and treatments currently available for small intestinal bacterial overgrowth (SIBO) in children. SIBO is a clinical entity characterized by the presence of an excessive number of bacteria in the small bowel leading to several nonspecific gastrointestinal symptoms due to malabsorption and malnutrition, such as bloating, flatulence, belching, diarrhea, abdominal pain, nausea, steatorrhea, fatigue and stunted growth. Initially thought to develop specifically in the context of abnormal or postsurgical gastrointestinal anatomy, it has then been recognized that it can be associated with other nonsurgical conditions, such as gastrointestinal dysmotility, disorders of gut–brain interactions and chronic use of drugs. The uncertainty regarding the exact cut‐off of excessive number of bacteria in the small bowel has led to the absence of a universally accepted definition of SIBO making well‐designed research to assess the best diagnostic and therapeutic approaches challenging. Current available diagnostic tools includes duodenal/jejunal aspirate with culture and hydrogen breath tests, which all have some limitations and pitfalls that prevent accurate sampling. The treatment goal should be to treat the underlying causes, restore the healthy intestinal microflora, relieve the symptoms and address the associated complications. The use of antibiotics represents the treatment cornerstore. However, they are commonly used despite the scarce published evidence and the absence of agreement on the dose and duration of the treatment. Currently, data on best diagnostic and therapeutic strategies in children remain lacking. Novel diagnostic approaches for SIBO are emerging and may facilitate further research.Keywords
This publication has 106 references indexed in Scilit:
- Factors associated with D‐lactic acidosis in pediatric intestinal failure: A case‐control studyJournal of Pediatric Gastroenterology and Nutrition, 2023
- ASPEN definitions in pediatric intestinal failureJournal of Parenteral and Enteral Nutrition, 2021
- European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensusUnited European Gastroenterology Journal, 2021
- Identification of volatile compounds from bacteria by spectrometric methods in medicine diagnostic and other areas: current state and perspectivesApplied Microbiology and Biotechnology, 2021
- Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutritionJGH Open, 2019
- Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot StudyJournal of Parenteral and Enteral Nutrition, 2018
- Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowthJournal of Gastroenterology, 2017
- Small Intestinal Bacterial Overgrowth in Patients With Lower Gastrointestinal Symptoms and a History of Previous Abdominal SurgeryArchives of Surgery, 2011
- Small Intestinal Bacterial OvergrowthJAMA, 2004
- Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's diseaseDiseases of the Colon & Rectum, 1999